Christian Bloomgren
President at Dominion Aesthetic Technologies, Inc.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Janet Campbell | F | - |
Dominion Aesthetic Technologies, Inc.
Dominion Aesthetic Technologies, Inc. Medical DistributorsDistribution Services Dominion Aesthetic Technologies, Inc. engages in the commercialization of medical devices in the aesthetic field. It offers skin tightening, body sculpting, laser hair removal, incontinence, skin and feminine rejuvenation services. The company was founded by Philip Lavin, Janet Campbell, and J. Arturo Bonilla in 2015 and is headquartered in San Antonio, TX. | 9 years |
Cooper Collins | M | 45 |
Dominion Aesthetic Technologies, Inc.
Dominion Aesthetic Technologies, Inc. Medical DistributorsDistribution Services Dominion Aesthetic Technologies, Inc. engages in the commercialization of medical devices in the aesthetic field. It offers skin tightening, body sculpting, laser hair removal, incontinence, skin and feminine rejuvenation services. The company was founded by Philip Lavin, Janet Campbell, and J. Arturo Bonilla in 2015 and is headquartered in San Antonio, TX. | 4 years |
Yash Sinha | M | - |
Dominion Aesthetic Technologies, Inc.
Dominion Aesthetic Technologies, Inc. Medical DistributorsDistribution Services Dominion Aesthetic Technologies, Inc. engages in the commercialization of medical devices in the aesthetic field. It offers skin tightening, body sculpting, laser hair removal, incontinence, skin and feminine rejuvenation services. The company was founded by Philip Lavin, Janet Campbell, and J. Arturo Bonilla in 2015 and is headquartered in San Antonio, TX. | 6 years |
Greg Watson | M | - |
Dominion Aesthetic Technologies, Inc.
Dominion Aesthetic Technologies, Inc. Medical DistributorsDistribution Services Dominion Aesthetic Technologies, Inc. engages in the commercialization of medical devices in the aesthetic field. It offers skin tightening, body sculpting, laser hair removal, incontinence, skin and feminine rejuvenation services. The company was founded by Philip Lavin, Janet Campbell, and J. Arturo Bonilla in 2015 and is headquartered in San Antonio, TX. | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Susan Mahony | M | 59 | 18 years | |
Marc Beer | M | 59 |
ViaCell, Inc.
ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | 7 years |
Ronald J. Kanterman | M | 69 |
AMAG Pharma USA, Inc.
AMAG Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharma USA, Inc. engages in the provision of pharmaceutical products to independent pharmacies, managed care organizations, hospitals, pharmacy benefit management companies, government entities, and physicians. The company was founded by Victor M. Hermelin in 1942 and is headquartered in Waltham, MA. | 5 years |
Ellen Marram | F | 77 | 17 years | |
Anat Ashkenazi | F | 51 | 23 years | |
Ronak H. Shah | M | - | 2 years | |
Win Bischoff | M | 81 | 14 years | |
Martin Feldstein | M | 84 | 10 years | |
Richard Ernest Gilbert | M | - | 12 years | |
Casey Logan | M | 52 | 6 years | |
Guosheng Wu | M | - | 1 years | |
Kimberly Marie Lein-Mathisen | F | 52 | 12 years | |
Andrea Cranfill | F | - | 1 years | |
Eugene V. DeFelice | M | 66 |
AMAG Pharma USA, Inc.
AMAG Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharma USA, Inc. engages in the provision of pharmaceutical products to independent pharmacies, managed care organizations, hospitals, pharmacy benefit management companies, government entities, and physicians. The company was founded by Victor M. Hermelin in 1942 and is headquartered in Waltham, MA. | 2 years |
Scott M. Stiffler | M | 54 | 7 years | |
Mitchell Daniels | M | 48 | 1 years | |
Howard Levy | M | 70 | - | |
Michael Schröter | M | - | 2 years | |
Armen Shanafelt | M | 64 | 7 years | |
Allen Shofe | M | - | 3 years | |
Patricia A. Johnston | M | - | 4 years | |
Vincent P. Mihalik | M | 73 | - | |
Carlos Paya | M | 65 | 7 years | |
Stéphane Bancel | M | 51 | 6 years | |
Robert Baughman | M | - | - | |
Peter Buhler | M | 54 | 2 years | |
Jennifer Gudeman | M | - |
AMAG Pharma USA, Inc.
AMAG Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharma USA, Inc. engages in the provision of pharmaceutical products to independent pharmacies, managed care organizations, hospitals, pharmacy benefit management companies, government entities, and physicians. The company was founded by Victor M. Hermelin in 1942 and is headquartered in Waltham, MA. | - |
Meghann York Meenan | F | - | 1 years | |
Lucas Montarce | M | 47 | - | |
Jesper Gromada | M | - | 6 years | |
Kimberly Mathisen, MBA | - | - | 12 years | |
Fadi Debes | M | - | - | |
Wen Bo Wang | M | - |
ViaCell, Inc.
ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | 4 years |
Michael Overdorf | M | 54 | 19 years | |
Scott Jacober | M | - | 18 years | |
Carl L. McMillian | M | 60 | - | |
Jamie Dananberg | M | 66 | 12 years | |
Michael Bumby | M | 60 | 11 years | |
Kathleen Hayes | F | - |
ViaCell, Inc.
ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | 4 years |
Michael Andriole | M | 51 | 16 years | |
Richard Mohs | M | - | 13 years | |
William Fodor | M | 65 |
ViaCell, Inc.
ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | 2 years |
Ben Harshbarger | M | 55 |
ViaCell, Inc.
ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | 2 years |
J. Ware | M | 71 | 17 years | |
Cezary Nadecki | M | - | 2 years | |
Paul Eisenberg | M | - | 3 years | |
Lisa Guttman | F | - | 10 years | |
Kirk T. Williamson | M | - |
ViaCell, Inc.
ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | - |
Joshua M. Salisbury | M | - | - | |
Oranee T. Daniels | M | - | 3 years | |
Nelson M. Sims | M | 76 | 28 years | |
Vaughn M. Kailian | M | 79 |
ViaCell, Inc.
ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | 3 years |
James S. Sigler | M | 63 |
ViaCell, Inc.
ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | 2 years |
John Thero | M | 63 |
ViaCell, Inc.
ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | - |
Jan van Heek | M | 75 |
ViaCell, Inc.
ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | 5 years |
George Myles Cordell Fisher | M | 84 | - | |
James Tullis | M | 77 |
ViaCell, Inc.
ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | 2 years |
Larry Ellingson | M | 78 | 30 years | |
Steve G. Dance | M | 72 |
ViaCell, Inc.
ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | 3 years |
Freda Lewis-Hall | M | 69 | 8 years | |
Raymond Joseph Hage | M | 56 | - | |
Anne Cook | F | 62 |
ViaCell, Inc.
ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | 2 years |
Stephan Wnendt | M | 61 |
ViaCell, Inc.
ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | - |
David A. van Vliet | M | 68 |
AMAG Pharma USA, Inc.
AMAG Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharma USA, Inc. engages in the provision of pharmaceutical products to independent pharmacies, managed care organizations, hospitals, pharmacy benefit management companies, government entities, and physicians. The company was founded by Victor M. Hermelin in 1942 and is headquartered in Waltham, MA. | 6 years |
Terry B. Hatfield | M | 76 |
AMAG Pharma USA, Inc.
AMAG Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharma USA, Inc. engages in the provision of pharmaceutical products to independent pharmacies, managed care organizations, hospitals, pharmacy benefit management companies, government entities, and physicians. The company was founded by Victor M. Hermelin in 1942 and is headquartered in Waltham, MA. | 6 years |
James L. Corbett | M | 61 |
ViaCell, Inc.
ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | - |
Jean M. Bellin | M | 74 |
AMAG Pharma USA, Inc.
AMAG Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharma USA, Inc. engages in the provision of pharmaceutical products to independent pharmacies, managed care organizations, hospitals, pharmacy benefit management companies, government entities, and physicians. The company was founded by Victor M. Hermelin in 1942 and is headquartered in Waltham, MA. | - |
William Ringo | M | 78 | 28 years | |
Michael L. Eagle | M | 76 | 8 years | |
Neal Fowler | M | 62 | 13 years | |
Jacques Messier | M | - |
AMAG Pharma USA, Inc.
AMAG Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharma USA, Inc. engages in the provision of pharmaceutical products to independent pharmacies, managed care organizations, hospitals, pharmacy benefit management companies, government entities, and physicians. The company was founded by Victor M. Hermelin in 1942 and is headquartered in Waltham, MA. | 2 years |
Justine E. Koenigsberg | F | - |
ViaCell, Inc.
ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | - |
Paul Truex | M | 55 | 3 years | |
Martin F. Haslanger | M | - | 9 years | |
Jerome H. Fleisch | M | - | 27 years | |
Scott Syphax | M | 60 | 2 years | |
James Posada | M | - | 4 years | |
Bryan Dunnivant | M | - | 3 years | |
Barbara Bierer | M | 70 |
ViaCell, Inc.
ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | 2 years |
David A. Broecker | M | 63 | 16 years | |
Stephen W. Kaldor | M | 62 | 12 years | |
Christoph Adams | M | 67 |
ViaCell, Inc.
ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | 4 years |
George Daley | M | - |
ViaCell, Inc.
ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | - |
Denise Scots-Knight | M | 64 |
ViaCell, Inc.
ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | - |
Morris Z. Rosenberg | M | 64 | 3 years | |
Brett L. Schmidli | M | 72 | 10 years | |
Paul Hastings | M | 64 |
ViaCell, Inc.
ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | 7 years |
Paul Blake | M | 76 |
ViaCell, Inc.
ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | 2 years |
Saul Factor | M | 65 | 3 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 93 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Christian Bloomgren
- Personal Network